(MYL:Consolidated Issue Listed on NASDAQ Global Select )
Randall L. Vanderveen Ph.D., B.C.P.P., F.A.Ph.A., F.A.S.H.P., R.Ph.
Director, Member of Compliance Committee and Member of Science & Technology Committee, Mylan, Inc.
|Age||Total Calculated Compensation||This person is connected to 13 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Dr. Randall L. Vanderveen, also known as Pete, Ph.D., BCPP, FAPhA, FASHP, R.PH. has been Dean and John Stauffer Chair of the University of Southern California School of Pharmacy since September 2005. Dr. Vanderveen served as Dean and Professor of Pharmacy at Duquesne University and Dean of the Graduate School of Pharmaceutical Sciences since 1998. Previously, he served in a variety of academic positions at Oregon State University/Oregon Health Sciences University and ...
1000 Mylan BoulevardPhone: 724-514-1800
Canonsburg, Pennsylvania 15317
Board Members Memberships*
Director, Member of Compliance Committee and Member of Science & Technology Committee
Michigan State University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|James T. Ryan||Chairman, Chief Executive Officer and President|
W.W. Grainger, Inc.
|Nitin Sahney||Chief Executive Officer, President and Director|
|Joseph C. Papa||Chairman, Chief Executive Officer and President|
Perrigo Company Public Limited Company
|John J. Engel||Chairman, Chief Executive Officer, President and Member of Executive Committee|
WESCO International Inc.
|Frederic Roch Doliveux DVM||Chief Executive Officer and Executive Director|
|€2.1M||Compensation as of Fiscal Year 2013.|